Hogge Gary S.
Insider CIK 1771711 · LCTX SVP,Clinical & Medical Affairs
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2023-03-09 | 2023-03-10 | 400,000 | — | $0 | 400,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise deriv | 2023-02-11 | 2023-02-14 | 13,020 | — | $0 | 39,061 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | F Tax w/h | 2023-02-11 | 2023-02-14 | 5,310 | $1.35 | $7.2K | 7,710 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise | 2023-02-11 | 2023-02-14 | 13,020 | — | $0 | 13,020 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2022-03-10 | 2022-03-11 | 450,000 | — | $0 | 450,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2022-02-11 | 2022-02-15 | 52,081 | — | $0 | 52,081 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise deriv | 2021-12-29 | 2021-12-30 | 9,250 | — | $0 | 249,750 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | S Sale | 2021-12-29 | 2021-12-30 | 28,445 | $2.44 | $69.4K | 0 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | S Sale | 2021-12-29 | 2021-12-30 | 9,250 | $2.49 | $23.0K | 28,445 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise | 2021-12-29 | 2021-12-30 | 9,250 | $0.69 | $6.4K | 37,695 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise deriv | 2021-12-28 | 2021-12-30 | 236,899 | — | $0 | 10,301 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise deriv | 2021-12-28 | 2021-12-30 | 185,000 | — | $0 | 259,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise deriv | 2021-12-28 | 2021-12-30 | 79,689 | — | $0 | 32,811 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | S Sale | 2021-12-28 | 2021-12-30 | 501,588 | $2.45 | $1.23M | 28,445 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise | 2021-12-28 | 2021-12-30 | 79,689 | $1.14 | $90.8K | 530,033 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise | 2021-12-28 | 2021-12-30 | 236,899 | $2.11 | $499.9K | 450,344 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise | 2021-12-28 | 2021-12-30 | 185,000 | $0.69 | $127.6K | 213,445 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2021-03-15 | 2021-03-17 | 419,500 | — | $0 | 419,500 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2020-03-17 | 2020-03-19 | 444,000 | — | $0 | 444,000 | SEC↗ |